Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026)
Novartis Ag (NVS) posted Goodwill & Intangibles of $12.7 billion for Q1 2026, down 76.9% sequentially from $55.0 billion in Q4 2025.
Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Novartis Ag (NVS) has 14 years of Goodwill & Intangibles data on file, last reported at $12.7 billion in Q1 2026.
- Quarterly Goodwill & Intangibles changed N/A year-over-year to $12.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.7 billion (changed N/A YoY) and the FY2025 annual result came in at $55.0 billion, up 6.4% from the prior year.
- Goodwill & Intangibles eased to $12.7 billion in Q1 2026 per NVS's latest filing, from $55.0 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $81.7 billion in Q4 2023, with the low at $162.0 million in Q3 2022.
- Average Goodwill & Intangibles over 5 years is $35.9 billion, with a median of $51.7 billion recorded in 2024.
- Year-over-year, Goodwill & Intangibles sank 62.76% in 2022 and surged 4795.74% in 2023.
- Novartis Ag's Goodwill & Intangibles stood at $26.7 billion in 2022, then soared by 206.21% to $81.7 billion in 2023, then sank by 36.72% to $51.7 billion in 2024, then increased by 6.4% to $55.0 billion in 2025, then sank by 76.9% to $12.7 billion in 2026.
- Business Quant data shows NVS's Goodwill & Intangibles at $12.7 billion in Q1 2026, $55.0 billion in Q4 2025, and $54.8 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.70 Bn |
| Dec 31, 2025 | 54.98 Bn |
| Jun 30, 2025 | 54.79 Bn |
| Dec 31, 2024 | 51.67 Bn |
| Jun 30, 2024 | 53.01 Bn |
| Dec 31, 2023 | 81.66 Bn |
| Jun 30, 2023 | 57.53 Bn |
| Dec 31, 2022 | 26.67 Bn |
| Sep 30, 2022 | 162.00 Mn |
| Jun 30, 2022 | 1.18 Bn |
| Dec 31, 2021 | 27.19 Bn |
| Sep 30, 2021 | 435.00 Mn |
| Jun 30, 2021 | 257.00 Mn |
| Mar 31, 2021 | 235.00 Mn |
| Dec 31, 2020 | 3.43 Bn |
| Sep 30, 2020 | 218.00 Mn |
| Jun 30, 2020 | 10.11 Bn |
| Dec 31, 2019 | 7.62 Bn |
| Jun 30, 2019 | 486.00 Mn |
| Mar 31, 2019 | 539.00 Mn |